↓ Skip to main content

Cochrane Database of Systematic Reviews

Postoperative tamoxifen for ductal carcinoma in situ

Overview of attention for article published in Cochrane database of systematic reviews, October 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (82nd percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
5 tweeters
wikipedia
3 Wikipedia pages
f1000
1 research highlight platform

Citations

dimensions_citation
49 Dimensions

Readers on

mendeley
163 Mendeley
Title
Postoperative tamoxifen for ductal carcinoma in situ
Published in
Cochrane database of systematic reviews, October 2012
DOI 10.1002/14651858.cd007847.pub2
Pubmed ID
Authors

Helen Staley, Iain McCallum, Julie Bruce

Abstract

Ductal carcinoma in situ (DCIS) is a non-invasive carcinoma of the breast. The incidence of DCIS has increased substantially over the last twenty years, largely as a result of the introduction of population-based mammographic screening. The treatment of DCIS tumours involves surgery with or without radiotherapy to prevent recurrent DCIS and invasive carcinoma. However, there is clinical uncertainty as to whether postoperative hormonal treatment (tamoxifen) after surgery confers benefit in overall survival and incidence of recurrent carcinoma.

Twitter Demographics

The data shown below were collected from the profiles of 5 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 163 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Canada 1 <1%
Unknown 162 99%

Demographic breakdown

Readers by professional status Count As %
Researcher 24 15%
Student > Master 23 14%
Student > Bachelor 19 12%
Student > Ph. D. Student 15 9%
Other 13 8%
Other 26 16%
Unknown 43 26%
Readers by discipline Count As %
Medicine and Dentistry 66 40%
Nursing and Health Professions 15 9%
Psychology 9 6%
Biochemistry, Genetics and Molecular Biology 7 4%
Agricultural and Biological Sciences 6 4%
Other 13 8%
Unknown 47 29%

Attention Score in Context

This research output has an Altmetric Attention Score of 8. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 September 2022.
All research outputs
#4,035,309
of 22,684,168 outputs
Outputs from Cochrane database of systematic reviews
#6,497
of 12,300 outputs
Outputs of similar age
#30,138
of 175,485 outputs
Outputs of similar age from Cochrane database of systematic reviews
#120
of 234 outputs
Altmetric has tracked 22,684,168 research outputs across all sources so far. Compared to these this one has done well and is in the 82nd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,300 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 30.3. This one is in the 47th percentile – i.e., 47% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 175,485 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 82% of its contemporaries.
We're also able to compare this research output to 234 others from the same source and published within six weeks on either side of this one. This one is in the 48th percentile – i.e., 48% of its contemporaries scored the same or lower than it.